Literature DB >> 11524496

Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.

S Kusunoki1, M Shiina, I Kanazawa.   

Abstract

The authors previously reported the presence of antibody against galactocerebroside (Gal-C) in sera from patients with Guillain-Barré syndrome subsequent to Mycoplasma pneumoniae infection. Anti-Gal-C antibody activities in these sera were inhibited specifically by the M. pneumoniae reagent. A rabbit anti-Gal-C antibody recognized several glycolipids in M. pneumoniae. These data show that a Gal-C-like structure is present in M. pneumoniae, indicative of molecular mimicry between a major myelin glycolipid, Gal-C, and M. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524496     DOI: 10.1212/wnl.57.4.736

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Authors:  Patrick M Meyer Sauteur; Adrianus C J M de Bruijn; Catarina Graça; Anne P Tio-Gillen; Silvia C Estevão; Theo Hoogenboezem; Rudi W Hendriks; Christoph Berger; Bart C Jacobs; Annemarie M C van Rossum; Ruth Huizinga; Wendy W J Unger
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 2.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

3.  A case report of Fisher syndrome with the detection of anti-GM3 and anti-GD1b IgG antibodies.

Authors:  Kosuke Matsuzono; Tadashi Ozawa; Keisuke Yoshikawa; Susumu Kusunoki; Shigeru Fujimoto
Journal:  Neurol Sci       Date:  2018-11-23       Impact factor: 3.307

4.  Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  J M Clain; A M Hummel; J H Stone; F C Fervenza; G S Hoffman; C G M Kallenberg; C A Langford; W J McCune; P A Merkel; P A Monach; P Seo; R F Spiera; E W St Clair; S R Ytterberg; U Specks
Journal:  Clin Exp Immunol       Date:  2017-02-07       Impact factor: 4.330

5.  O-linked protein glycosylation in Mycoplasma.

Authors:  David S Jordan; James M Daubenspeck; Audra H Laube; Matthew B Renfrow; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2013-10-18       Impact factor: 3.501

6.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

7.  Mycoplasma pneumoniae-induced rash and mucositis: a recently described entity.

Authors:  Rui Pedro Santos; Marta Silva; Ana Paula Vieira; Celeste Brito
Journal:  BMJ Case Rep       Date:  2017-08-22

8.  Rhamnose biosynthesis in mycoplasmas requires precursor glycans larger than monosaccharide.

Authors:  David S Jordan; James M Daubenspeck; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2013-07-19       Impact factor: 3.501

Review 9.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 10.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.